EFFECT OF ARTESUNATE, ESOMEPRAZOLE AND COFFEE INTAKE ON PRODROMAL PARKINSON’S DISEASE FEATURES IN ADULT MEN
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 12
Abstract
The convergent molecular mechanisms of aging, type 2 diabetes mellitus, Alzheimer’s disease, Parkinson’s disease and Huntington’s disease offer druggable targets. Present drugs for treatment of Parkinson’s disease (PD) often fail to maintain steady efficacy and are often associated with undesirable side- effects There is now a paradigm shift in this age-related neurodegenerative disorder to agents that co-operatively target immune activation, the noxious agents-induced ATP-P2X7 cell death receptor-NLRP3inflammasome-adenosine A2A receptor-HMGBI signalling, upregulate the anti-oxidant Nrf-2/ARE axis, insulin signalling, and enhance mitochondrial function to attenuate the hallmarks of this intriguing disease. Animal experimentations demonstrated that artesunate (30 mg/kg) has a significant additive effect (P < 0.05) with caffeine (6 mg/kg) in lowering glucose and uric acid levels in ad libitum high-lipid + low-dose streptozotocin-induced type 2 diabetic male mice compared to controls. In the clinical work, the effect of low-dose artesunate (12.5 mg daily) and low-dose esomeprazole (10 mg daily) use in conjunction with coffee intake was investigated in 5 elderly patients with prodromal Parkinson’s disease who had non-motor symptoms and the motor symptoms of bradykinesia, tremors, rigidity and postural imbalance. 3 weeks institution of the combined therapy significantly (P < 0.05) abrogated the postural imbalance, tremors and rigidity; and improved the bradykinesia, rapid eye movement sleep behavioural disorder and memory decline. The implication of the present study is that the combined remedies deserve more attention in the prevention of the progression and treatment not only of Parkinson’s disease but also of other age-related neurodegenerative disorders.
Authors and Affiliations
Dr. S. E. Oriaifo
TARGETING LTB4 –BLT1 – IN DIABETIC NEPHROPATHY?
Lipid mediators play important role in renal injury many of lipid mediators are expressed and up regulated in response to toxins, drugs and in metabolic disorder. Lipid mediators also play role in vascular complication....
ROLE OF VAJIGANDHADI TAILA IN THE MANAGEMENT OF SCIATICA
Sciatica is a symptom rather than a specific diagnosis. Available evidence from basic science and clinical research indicates that both inflammation and compression are important in order for the nerve root to be symptom...
PREVALENCE OF MAJOR SALIVARY GLAND TUMORS AT ALMOUASAT UNIVERSITY HOSPITAL
Objective: this study aimed to study the prevalence and incidence of Salivary gland tumors. Materials and Methods: This is a retrospective study of salivary gland tumors diagnosed between 1/1/2014 to 30/7/2018 from AlMou...
EVALUATION AS TO WHETHER ALOCASIA FORNICATA CAN AUGMENT BLOOD GLUCOSE LOWERING EFFECTS OF GLIBENCLAMIDE
Background: Alocasia fornicata whole plant methanolic extract has been reported previously to improve oral glucose tolerance that is lower blood glucose levels in glucose-challenged mice. As such, it was of interest to e...
FAST DISSOLVING TABLETS: PATIENT COMPLIANCE DOSAGE FORMS
Recent advances in Novel Drug Delivery System (NDDS) aim to enhance safety and efficacy of already used drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance. T...